JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HARRISON, L. A.
Right arrow Articles by JACOBSON, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HARRISON, L. A.
Right arrow Articles by JACOBSON, E. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 169, Issue 2, 321-327, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF OUABAIN ON THE SPLANCHNIC CIRCULATION

LURA ANN HARRISON 1, JON BLASCHKE 1, ROBERT S. PHILLIPS 1, WILLIAM E. PRICE 1, MARION deV. COTTEN 1, and EUGENE D. JACOBSON 1

1 Departments of Physiology and Biophysias, Pharmacology and Surgery, University of Oklahoma Medical Center, Oklahoma City, Oklahoma

Previous investigations have suggested that admin-istration of cardiac glycosides to the normal dog results in sequestration of blood in the splanchnic bed, which diminishes the venous return and cardiac output. The aim of this study was to evaluate and quantify splanchnic hemodynamic changes caused by administration of ouabain. The dogs were anesthetized with chioralose (50 mg kg-1) and urethane (550 mg kg-1). Direct measurements of mesenteric artery and splenic artery blood flow were obtained with electromagnetic blood flow transducers, systemic arterial and portal venous pressures with strain-gauge transducers, intestinal and splenic weight changes with a strain-gauge weighing device, and liver blood volume with I181-albumin injection and punch biopsies. These parameters were monitored before and after injection of ouabain (50 µg kg-1). We found the following responses to ouabain: 1) significant increases in systemic arterial pressure and calculated splenic and mesenteric vascular resistances and 2) no significant changes in portal venous pressure, splenic or mesenteric blood flow, organ weights or liver blood volume. From these findings, we conclude that there is no evidence for splanchnic congestion with therapeutic doses of ouabain and that the major splanchnic vascular event induced by ouabain is arteriolar vasoconstriction.

Submitted on March 19, 1969
Accepted on June 20, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.